Article Information
- Received February 25, 2014
- Revision received April 24, 2014
- Accepted April 29, 2014
- First published June 18, 2014.
- Version of record published June 18, 2014.
Author Information
Author contributions
Author contributions: B.E.W., S.L., and X.-J.L. designed research; B.E.W., C.-E.W., S.Y., K.B., and B.H. performed research; B.E.W. and X.-J.L. analyzed data; B.E.W., S.L., and X.-J.L. wrote the paper.
Disclosures
- Received February 25, 2014.
- Revision received April 24, 2014.
- Accepted April 29, 2014.
This work was supported by National Institutes of Health Grants AG19206 and NS041449 (to X.-J.L.); and AG031153 and NS0405016 (to S.L.). This research project was supported in part by the Viral Vector Core of the Emory National Institute of Neurological Disorders and Stroke Core Facilities Grant P30NS055077. We thank Matthew Randolph for technical assistance in muscle injection and stereotaxic surgery, Dr. Michael Epstein for recommendations in statistical analysis, Cheryl Strauss for critically reading this manuscript, and Dr. Nick Seyfried for the SUMO-2/3 antibody.
The authors declare no competing financial interests.
- Correspondence should be addressed to Dr. Xiao-Jiang Li, Department of Human Genetics, Emory University School of Medicine, 615 Michael Street, Room 347, Atlanta, GA 30322. xli2{at}emory.edu
